Clinical trial

Multimodal Deep Learning for the Diagnosis and Assessment of Alzheimer's Disease

NCT06081569

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention gait video; speech video; facial expression video; Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Multimodal Deep Learning for the Diagnosis and Assessment of Alzheimer's Disease

Design: OBSERVATIONAL · Status: NOT YET RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeOBSERVATIONAL

Start date2023-10-15

PhaseN/A

Conditions

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Mild Cognitive Impairmentunresolved

Interventions

gait video; speech video; facial expression video;DIAGNOSTIC_TEST

Sponsors & collaborators

First Hospital of China Medical Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06081569 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.